These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8552900)

  • 1. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.
    Shih WJ; Gould AL
    Stat Med; 1995 Oct; 14(20):2239-48. PubMed ID: 8552900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods for adaptive sample size adjustment.
    Friede T; Kieser M
    Stat Med; 2001 Dec; 20(24):3861-73. PubMed ID: 11782039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample Size Re-Estimation without Breaking the Blind in Clinical Trial.
    Wu CH
    J Biopharm Stat; 2015; 25(5):1114-29. PubMed ID: 25630031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes.
    Shih WJ; Zhao PL
    Stat Med; 1997 Sep; 16(17):1913-23. PubMed ID: 9304763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Gould-Shih procedure for sample size re-estimation.
    Waksman JA
    Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal pilot studies II: comparison of various procedures.
    Zucker DM; Wittes JT; Schabenberger O; Brittain E
    Stat Med; 1999 Dec; 18(24):3493-509. PubMed ID: 10611621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SAS macro for sample size re-estimation.
    Zellner D; Zellner GE; Keller F
    Comput Methods Programs Biomed; 2001 Jun; 65(3):183-90. PubMed ID: 11339980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blind outcome assessment: the development and use of procedures to maintain and describe blinding in a pragmatic physiotherapy rehabilitation trial.
    Minns Lowe CJ; Wilson MS; Sackley CM; Barker KL
    Clin Rehabil; 2011 Mar; 25(3):264-74. PubMed ID: 20971749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration.
    Burback D; Molnar FJ; St John P; Man-Son-Hing M
    Dement Geriatr Cogn Disord; 1999; 10(6):534-40. PubMed ID: 10559571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifying the design of ongoing trials without unblinding.
    Gould AL; Shih WJ
    Stat Med; 1998 Jan; 17(1):89-100. PubMed ID: 9463852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
    van Schie S; Moerbeek M
    Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exact test size and power of a Gaussian error linear model for an internal pilot study.
    Coffey CS; Muller KE
    Stat Med; 1999 May; 18(10):1199-214. PubMed ID: 10363340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size re-estimation: recent developments and practical considerations.
    Gould AL
    Stat Med; 2001 Sep 15-30; 20(17-18):2625-43. PubMed ID: 11523073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning and revising the sample size for a trial.
    Gould AL
    Stat Med; 1995 May 15-30; 14(9-10):1039-51; discussion 1053-5. PubMed ID: 7569499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.